Inhibrx Biosciences Inc (INBX)

Finanzdaten der Inhibrx Biosciences Inc-Aktie (INBX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	1.30
	3.95%32.15	30.93	30.92	33.81	28.69
Research and Development	5.23%23.90	25.22	25.35	28.54	22.27
Operating Income/Loss	3.95%-32.15	-30.93	-30.92	-33.81	-27.39
Nonoperating Income/Loss	78.92%-4.50	-2.51	-1.91	-1.44	-1.26
Income/Loss From Continuing Operations Before Tax	9.59%-36.65	-33.44	-32.83	-35.26	-28.65
Income Tax Expense/Benefit	0.00	-	-	-	0.00
	9.60%-36.65	-33.44	-32.83	-35.26	-28.65
Attributable To Parent	9.60%-36.65	-33.44	-32.83	-35.26	-28.65
Basic Average Shares	0.54%15.67	15.59	-	15.48	15.47
Diluted Average Shares	0.54%15.67	15.59	-	15.48	15.47
Basic Earnings Per Share	8.84%-2.34	-2.15	-	-2.28	-1.85
Diluted Earnings Per Share	8.84%-2.34	-2.15	-	-2.28	-1.85